Filer Snapshot

Srdjan R. Stankovic

CIK 0001432545. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

35

Latest filing

22 Nov 2022

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for ACAD. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open owner activity Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Forms 3/4/5

4 filed on 22 Nov 2022 for CIK 0001432545.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$1.83M

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$1.83M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

ACAD
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
C/O Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130

Filer intelligence

What SEC filings say about Srdjan R. Stankovic

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • Forms 3/4/5 show insider context for ACAD worth $1.83M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

ACAD

19 Nov 2022 · President

$1.83M
Issuer page Owner page

Latest update

What changed recently for Srdjan R. Stankovic

Ownership report updated

Latest ownership report period: 19 Nov 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

22 Nov 2022

Page type

Ownership filings

Latest period

19 Nov 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 22 Nov 2022.

Open ownership filings Browse recent public updates

SEC filing record

CIK 0001432545 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
35
First seen
24 Apr 2008
Latest filing
22 Nov 2022
Entity
Individual

Observed form types

4 3 3/A

CIK-linked evidence first

Srdjan R. Stankovic SEC filings Srdjan R. Stankovic owner filings Open SEC filing index

Latest Filings

Showing the latest 12 of 31 SEC filings for Srdjan R. Stankovic.

Open full filing history
4 File 000-50768

FORM 4 SUBMISSION

Filing date
22 Nov 2022
Reporting date
19 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
18 Oct 2022
Reporting date
15 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
03 May 2022
Reporting date
29 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
07 Apr 2022
Reporting date
05 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
25 Feb 2022
Reporting date
23 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
10 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
19 Oct 2021
Reporting date
15 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
30 Apr 2021
Reporting date
29 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
25 Feb 2021
Reporting date
23 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
08 Feb 2021
Reporting date
04 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 000-50768

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
12 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .